Cargando…

473. Using Serosurveillance for SARS-CoV-2 to Conserve PCR Tests in a Resource Constrained Combat Environment

BACKGROUND: In March 2020, COVID-19 threatened combat operations in Afghanistan. At that time, the NATO Resolute Support mission involved nearly 17,000 troops from 38 partner nations, plus civilians who support the mission, scattered throughout Afghanistan. While Afghanistan did not initially report...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Brian K, Sachdeva, Mohit, Bova, Jacob, Nichols, Shawnn, Stuart, Rory P, Rutherford, Ashley E, Comes, Ryan, Cybulski, Daniel, Case, Alex M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777134/
http://dx.doi.org/10.1093/ofid/ofaa439.666
_version_ 1783630833858379776
author White, Brian K
Sachdeva, Mohit
Bova, Jacob
Nichols, Shawnn
Stuart, Rory P
Rutherford, Ashley E
Comes, Ryan
Cybulski, Daniel
Case, Alex M
author_facet White, Brian K
Sachdeva, Mohit
Bova, Jacob
Nichols, Shawnn
Stuart, Rory P
Rutherford, Ashley E
Comes, Ryan
Cybulski, Daniel
Case, Alex M
author_sort White, Brian K
collection PubMed
description BACKGROUND: In March 2020, COVID-19 threatened combat operations in Afghanistan. At that time, the NATO Resolute Support mission involved nearly 17,000 troops from 38 partner nations, plus civilians who support the mission, scattered throughout Afghanistan. While Afghanistan did not initially report many confirmed cases, large numbers of cases were reported from neighboring countries with known migration across the borders (sometimes thousands/day). Military medical leaders advised commanders regarding the potential health risks to the force, balancing with risks to the mission. Quarantine and isolation protocols were established. Public health interventions of social distancing, cloth mask wear, enhanced environmental cleaning, active case finding, and emphasis on hand hygiene and cough etiquette were enforced. However, many base locations were unable to alleviate close living quarters. Testing was identified as a means to assess risk to the population. Testing capabilities were limited, particularly PCR. When this testing strategy was established, the utilization and interpretation of antibody tests was quite controversial. With rapid antibody kits, the time to detection of both IgM and IgG are similar; detection of either cannot identify the time since exposure. METHODS: A novel surveillance plan was established whereby subpopulations at highest risk for exposure to the virus were screened with antibody tests from 17 Apr-1 Jun, 2020. High risk populations included: those leaving quarantine, base defense guards, isolation unit guards, medical personnel, dining facility workers, and those who interact with local populations. Individuals with detectable antibody (either IgM or IgG) were further evaluated with PCR tests. RESULTS: In the first six weeks of this testing strategy, 1957 antibody tests were utilized. A total of 37 specimens were identified antibody positives with seroprevalence of 2% (Figure 1). Thirteen were identified to have positive IgG, 22 with IgM, and 2 with both. PCR was performed on those with detectable antibody, 13 (35%) had positive PCR. CONCLUSION: Serosurveillance of populations at high risk for exposure to the virus is a logical way to conserve testing resources in a constrained combat environment. DISCLOSURES: Alex M. Case, n/a, United States Air Force (Employee)
format Online
Article
Text
id pubmed-7777134
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77771342021-01-07 473. Using Serosurveillance for SARS-CoV-2 to Conserve PCR Tests in a Resource Constrained Combat Environment White, Brian K Sachdeva, Mohit Bova, Jacob Nichols, Shawnn Stuart, Rory P Rutherford, Ashley E Comes, Ryan Cybulski, Daniel Case, Alex M Open Forum Infect Dis Poster Abstracts BACKGROUND: In March 2020, COVID-19 threatened combat operations in Afghanistan. At that time, the NATO Resolute Support mission involved nearly 17,000 troops from 38 partner nations, plus civilians who support the mission, scattered throughout Afghanistan. While Afghanistan did not initially report many confirmed cases, large numbers of cases were reported from neighboring countries with known migration across the borders (sometimes thousands/day). Military medical leaders advised commanders regarding the potential health risks to the force, balancing with risks to the mission. Quarantine and isolation protocols were established. Public health interventions of social distancing, cloth mask wear, enhanced environmental cleaning, active case finding, and emphasis on hand hygiene and cough etiquette were enforced. However, many base locations were unable to alleviate close living quarters. Testing was identified as a means to assess risk to the population. Testing capabilities were limited, particularly PCR. When this testing strategy was established, the utilization and interpretation of antibody tests was quite controversial. With rapid antibody kits, the time to detection of both IgM and IgG are similar; detection of either cannot identify the time since exposure. METHODS: A novel surveillance plan was established whereby subpopulations at highest risk for exposure to the virus were screened with antibody tests from 17 Apr-1 Jun, 2020. High risk populations included: those leaving quarantine, base defense guards, isolation unit guards, medical personnel, dining facility workers, and those who interact with local populations. Individuals with detectable antibody (either IgM or IgG) were further evaluated with PCR tests. RESULTS: In the first six weeks of this testing strategy, 1957 antibody tests were utilized. A total of 37 specimens were identified antibody positives with seroprevalence of 2% (Figure 1). Thirteen were identified to have positive IgG, 22 with IgM, and 2 with both. PCR was performed on those with detectable antibody, 13 (35%) had positive PCR. CONCLUSION: Serosurveillance of populations at high risk for exposure to the virus is a logical way to conserve testing resources in a constrained combat environment. DISCLOSURES: Alex M. Case, n/a, United States Air Force (Employee) Oxford University Press 2020-12-31 /pmc/articles/PMC7777134/ http://dx.doi.org/10.1093/ofid/ofaa439.666 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
White, Brian K
Sachdeva, Mohit
Bova, Jacob
Nichols, Shawnn
Stuart, Rory P
Rutherford, Ashley E
Comes, Ryan
Cybulski, Daniel
Case, Alex M
473. Using Serosurveillance for SARS-CoV-2 to Conserve PCR Tests in a Resource Constrained Combat Environment
title 473. Using Serosurveillance for SARS-CoV-2 to Conserve PCR Tests in a Resource Constrained Combat Environment
title_full 473. Using Serosurveillance for SARS-CoV-2 to Conserve PCR Tests in a Resource Constrained Combat Environment
title_fullStr 473. Using Serosurveillance for SARS-CoV-2 to Conserve PCR Tests in a Resource Constrained Combat Environment
title_full_unstemmed 473. Using Serosurveillance for SARS-CoV-2 to Conserve PCR Tests in a Resource Constrained Combat Environment
title_short 473. Using Serosurveillance for SARS-CoV-2 to Conserve PCR Tests in a Resource Constrained Combat Environment
title_sort 473. using serosurveillance for sars-cov-2 to conserve pcr tests in a resource constrained combat environment
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777134/
http://dx.doi.org/10.1093/ofid/ofaa439.666
work_keys_str_mv AT whitebriank 473usingserosurveillanceforsarscov2toconservepcrtestsinaresourceconstrainedcombatenvironment
AT sachdevamohit 473usingserosurveillanceforsarscov2toconservepcrtestsinaresourceconstrainedcombatenvironment
AT bovajacob 473usingserosurveillanceforsarscov2toconservepcrtestsinaresourceconstrainedcombatenvironment
AT nicholsshawnn 473usingserosurveillanceforsarscov2toconservepcrtestsinaresourceconstrainedcombatenvironment
AT stuartroryp 473usingserosurveillanceforsarscov2toconservepcrtestsinaresourceconstrainedcombatenvironment
AT rutherfordashleye 473usingserosurveillanceforsarscov2toconservepcrtestsinaresourceconstrainedcombatenvironment
AT comesryan 473usingserosurveillanceforsarscov2toconservepcrtestsinaresourceconstrainedcombatenvironment
AT cybulskidaniel 473usingserosurveillanceforsarscov2toconservepcrtestsinaresourceconstrainedcombatenvironment
AT casealexm 473usingserosurveillanceforsarscov2toconservepcrtestsinaresourceconstrainedcombatenvironment